106 related articles for article (PubMed ID: 82581)
1. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
Haughton G; Lanier LL; Babcock GF; Lynes MA
J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
[TBL] [Abstract][Full Text] [Related]
2. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
3. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
6. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2.
Lynes MA; Lanier LL; Babcock GF; Wettstein PJ; Haughton G
J Immunol; 1978 Dec; 121(6):2352-7. PubMed ID: 363945
[TBL] [Abstract][Full Text] [Related]
7. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
8. Antigen receptors on murine T lymphocytes in contact sensitivity. II. Presentation and characterization of syngeneic anti-idiotype serum against DNFB-sensitized T cells.
Moorhead JW; Sy MS
J Immunol; 1982 Jun; 128(6):2533-8. PubMed ID: 6176644
[TBL] [Abstract][Full Text] [Related]
9. Description of a murine B lymphoma tumor-specific antigen.
Koch S; Zalcberg JR; McKenzie IF
J Immunol; 1984 Aug; 133(2):1070-7. PubMed ID: 6203965
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
[TBL] [Abstract][Full Text] [Related]
11. Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.
Bankert RB; Yokota S; Ghosh SK; Mayhew E; Jou YH
Cancer Res; 1989 Jan; 49(2):301-8. PubMed ID: 2783380
[TBL] [Abstract][Full Text] [Related]
12. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
13. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
Kwak LW; Campbell M; Levy R
Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
[TBL] [Abstract][Full Text] [Related]
14. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
15. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
Kaminski MS; Kitamura K; Maloney DG; Levy R
J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
17. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
18. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
Kawahara DJ; Marrack P; Kappler JW
J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
[TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
[TBL] [Abstract][Full Text] [Related]
20. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]